College of Medicine, Central Michigan University, Mount Pleasant, Michigan, USA.
Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.
Neurourol Urodyn. 2024 Mar;43(3):565-573. doi: 10.1002/nau.25416. Epub 2024 Feb 9.
Overactive bladder management includes multiple therapeutic options with comparable efficacy but a range of administration modalities and side effects, creating an ideal setting for shared decision-making. This study investigates patient and physician health beliefs surrounding decision-making and expectations for overactive bladder with the aim of better understanding and ultimately improving decision-making in overactive bladder care.
Patient and physician participants completed a questionnaire followed by a semi-structured interview to assess health beliefs surrounding decision making and expectations for overactive bladder treatment. The semi-structured interview guide, developed in an iterative fashion by the authors, probed qualities of overactive bladder therapies patients and physicians valued, their process of treatment selection, and their experiences with therapies.
Patients (n = 20) frequently cited treatment invasiveness, efficacy, and safety as the most important qualities that influenced their decision when selecting overactive bladder therapy. Physicians (n = 12) frequently cited safety/contraindications, convenience, cost/insurance, and patient preference as the most important qualities. In our integration analysis, we identified four key themes associated with decision making in overactive bladder care: frustration with inaccessibility of overactive bladder treatments, discordant perception of patient education, diverging acceptability of expected outcomes, and lack of insight into other parties' decisional priorities and control preferences.
While both patients and physicians desire to engage in a shared decision-making process when selecting therapies for overactive bladder, this process is challenged by significant divergence between patient and physician viewpoint across key domains.
治疗膀胱过度活动症的方法包括多种疗效相当但给药方式和副作用各异的治疗选择,这为共同决策提供了理想的条件。本研究旨在更好地理解并最终改善膀胱过度活动症治疗中的决策制定,调查了患者和医生在决策制定以及对膀胱过度活动症治疗的期望方面的健康信念。
患者和医生参与者完成了一份问卷,然后进行半结构化访谈,以评估围绕决策制定和对膀胱过度活动症治疗的期望的健康信念。半结构化访谈指南由作者以迭代方式制定,深入探究了患者和医生重视的膀胱过度活动症治疗的特性、他们的治疗选择过程以及他们对治疗的经验。
患者(n=20)经常将治疗的侵入性、疗效和安全性列为选择膀胱过度活动症治疗时最重要的影响因素。医生(n=12)经常将安全性/禁忌证、便利性、成本/保险和患者偏好列为最重要的因素。在我们的整合分析中,我们确定了与膀胱过度活动症护理决策相关的四个关键主题:对膀胱过度活动症治疗的可及性感到沮丧、对患者教育的看法不一致、对预期结果的可接受性存在分歧,以及缺乏对其他各方决策优先级和控制偏好的了解。
虽然患者和医生都希望在选择膀胱过度活动症治疗方法时参与共同决策过程,但在关键领域,患者和医生的观点存在显著差异,这给该过程带来了挑战。